Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival
Authors
Keywords
-
Journal
Clinical Respiratory Journal
Volume 9, Issue 4, Pages 457-467
Publisher
Wiley
Online
2014-05-12
DOI
10.1111/crj.12163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- αv-Integrin isoform expression in primary human tumors and brain metastases
- (2013) Alexander Vogetseder et al. INTERNATIONAL JOURNAL OF CANCER
- Highly Invasive Melanoma Cells Activate the Vascular Endothelium via an MMP-2/Integrin αvβ5–Induced Secretion of VEGF-A
- (2012) Anna Desch et al. AMERICAN JOURNAL OF PATHOLOGY
- The matrix protein CCN1/CYR61 is required for αVβ5-mediated cancer cell migration
- (2012) Jana Jandova et al. CELL BIOCHEMISTRY AND FUNCTION
- Defining the Role of Integrin αvβ6 in Cancer
- (2012) A. Bandyopadhyay et al. CURRENT DRUG TARGETS
- Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model
- (2012) Y. Jeffrey Wu et al. JOURNAL OF NEURO-ONCOLOGY
- Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis
- (2012) Feng Li et al. PATHOLOGY RESEARCH AND PRACTICE
- EGFR-Mediated Carcinoma Cell Metastasis Mediated by Integrin αvβ5 Depends on Activation of c-Src and Cleavage of MUC1
- (2012) Steven K. M. Lau et al. PLoS One
- Integrins as therapeutic targets
- (2012) Simon L. Goodman et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Matched rabbit monoclonal antibodies against v-series integrins reveal a novel v 3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
- (2012) S. L. Goodman et al. Biology Open
- Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing
- (2010) Coert Margadant et al. EMBO REPORTS
- Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study
- (2010) Tobias Bäuerle et al. INTERNATIONAL JOURNAL OF CANCER
- The final steps of integrin activation: the end game
- (2010) Sanford J. Shattil et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
- (2009) Jill M. Ricono et al. CANCER RESEARCH
- Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung
- (2009) Ludmila Prudkin et al. MODERN PATHOLOGY
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Activation of tumor cell integrin v 3 controls angiogenesis and metastatic growth in the brain
- (2009) M. Lorger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CYR61 and V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
- (2008) Y. Monnier et al. CANCER RESEARCH
- Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme
- (2008) David A Reardon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More